Merck Has An Upcoming PDUFA Date For Bezlotoxumab
October 21, 2016 at 16:45 PM EDT
Merck & Co., Inc. (NYSE: MRK) announced it has an upcoming PDUFA date on October 23. The FDA has accepted for review Merck's Biologics ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.